Nearly Half of Celiac Patients in New Study Had Inflammatory Back Pain
A new study found inflammatory back pain in 43.9% of celiac patients and sacroiliitis in one-third of those scanned — a joint condition that often goes undetected.
Understanding the medical, biological, and scientific aspects of celiac disease. From diagnosis to treatment, myths to facts.
Celiac disease is an autoimmune condition affecting roughly 1 in 100 people worldwide, yet the majority remain undiagnosed. When someone with celiac disease eats gluten — a protein found in wheat, barley, and rye — their immune system attacks the lining of the small intestine, damaging the villi that absorb nutrients from food.
This section covers the science behind celiac disease in plain language. We break down how gluten triggers an autoimmune response, what happens during the diagnostic process (blood tests, biopsies, and genetic markers), and why celiac disease is so frequently misdiagnosed or overlooked entirely.
Whether you've just been diagnosed, suspect you might have celiac disease, or want to understand what's happening in your body, these guides are written for patients — not textbooks. Every article is sourced from peer-reviewed research, medical institutions, and established organizations like the Celiac Disease Foundation and Beyond Celiac.
If you're newly diagnosed and feeling overwhelmed, start with our beginner's guide to celiac disease. For a deeper look at the protein that causes it all, read our complete guide to understanding gluten.
Beyond the basics, this section tracks the science as it evolves: how celiac disease is diagnosed (and why genetic testing alone can't confirm it), the difference between celiac disease, non-celiac gluten sensitivity, and a wheat allergy, and the growing pipeline of treatments being studied beyond the gluten-free diet — from enzyme therapies to immune-modulating drugs. We separate what's proven from what's promising, and we cite the research so you can check it yourself.
A new study found inflammatory back pain in 43.9% of celiac patients and sacroiliitis in one-third of those scanned — a joint condition that often goes undetected.
FDA allergen rules require wheat disclosure — but barley and rye are exempt. Here's why celiac families need to look beyond the allergen box on every label.
Tasting Table spotlighted a new gluten-free treat at Costco. Here's what the bulk-retail GF trend means for celiac families — and how to shop the warehouse aisle safely.
New pediatric research shows celiac disease produces distinctive patterns throughout the upper GI tract, with implications for diagnostic endoscopy.
Spanish supermarket Eroski reports gluten-free customers are unusually loyal. For celiac families, the reason is obvious — and retailers are noticing.
Not all gluten-free sections are equally safe for celiac families. Here's what sets these five grocery stores apart—and what to watch at every one.
The Celiac Cruise hits 35 sailings—and the onboard fundraiser helping low-income celiac families afford the gluten-free diet they need.
New research from Seattle Children's Hospital finds children diagnosed with celiac by blood test alone do just as well in follow-up care as those who had a biopsy.
The FDA is moving to improve gluten ingredient disclosure on food labels—closing gaps that have long put celiac patients at risk. Here's what's changing.
The Celiac Disease Foundation secured a record 30 government proclamations for Celiac Disease Awareness Month in 2026. Here's what that means for celiac families.
New research finds celiac kids on a strict GFD gain weight—but not height. Here's what that means for parents and dietary counseling.
New research finds celiac disease affects 1 in 100 residents of Northwest China—and appears six times more often in people with kidney disease.
Colombian entrepreneur Pilar Rengifo built The Choclo around naturally gluten-free Andean corn. Here's why this business model matters for celiac families.
New research links food insecurity and disordered eating attitudes to worse GFD adherence, more symptoms, and lower quality of life in celiac patients.
New research documents the psychological and social burden women with celiac disease carry—and finds it extends far beyond dietary restrictions.
New lab research finds black soybean peptides may reduce the oxidative damage gluten causes in celiac intestinal cells — what this early finding means for families.
A new study found 42.6% of children with celiac disease also have ARFID, a serious food-avoidance disorder tied to lower weight, weaker bones, and higher anxiety. What parents should know.
A new matched cohort study confirms celiac disease raises long-term risks of heart disease, lymphoma, and death—and why strict GF adherence is the best protection.
New research follows children with positive celiac tests but no intestinal damage — and finds outcomes vary widely among kids with potential celiac disease.
A new study tracks nutrition in celiac children after diagnosis, finding 1 in 4 still vitamin D deficient and overweight rates more than doubled at 12 months.
A Philadelphia biotech raised $15.1M to develop cell-based therapies for autoimmune disease. Here's what that investment signals for celiac families watching the treatment pipeline.
New research shows IFABP blood levels track real intestinal healing in celiac disease—detecting gut damage even when standard antibody tests look normal.
A new review in Autoimmunity Reviews shows celiac disease disrupts gut bacteria in ways the gluten-free diet doesn't fully reverse—and points toward new treatments.
A new study finds 20% of children diagnosed with celiac have the ultra-short variant—and standard biopsies miss them. Here's what families should know.
A new case report shows undiagnosed celiac disease can cause Wernicke encephalopathy — a brain disorder doctors typically attribute to alcohol dependence.
A large Spanish multicenter study from GETECCU examines how having celiac disease changes the clinical course of inflammatory bowel disease—and why that matters for families.
New research finds children with celiac disease have more sleep problems — and those not following a gluten-free diet sleep worst of all.
New computer modeling reveals how two underexplored genetic variants — HLA-DQ5 and DQ9 — can drive celiac disease in patients who lack the classic risk genes.
A controlled study finds celiac children score significantly higher on ADHD, cognitive disengagement syndrome, depression, and anxiety than peers without celiac.
Almond & Berry in Rhinelander, WI just turned one. What a dedicated gluten-free bakery surviving in a small city tells us about celiac families and demand.
A Danish nationwide study tracks sick leave before and after celiac diagnosis—putting hard numbers on a burden patients have described for years.
New research links persistent celiac symptoms to bacterial overgrowth in the small intestine—not gluten exposure. Here's what celiac families need to know.
A university in India's celiac hotspot secures new research funding. Here's why global celiac science—from unexpected places—matters for patients and families everywhere.
FDA approval alone won't get new celiac treatments to patients. Here's what the 2026 National Celiac Disease Policy Symposium revealed about the real challenge ahead.
New research shows children with type 1 diabetes or thyroid disease are far more likely to have asymptomatic celiac—making targeted screening essential.
New research shows celiac disease alters bone shape and structure at the hip, raising fracture risk beyond what standard bone density tests reveal.
Labs calibrating celiac blood tests have struggled with scarce reference samples. New synthetic antibodies may finally fix that gap in diagnostic accuracy.
A new review identifies exosomes as key players in celiac disease, with potential as non-invasive biomarkers for diagnosis and targets for new treatments.
A new prospective study finds celiac disease hiding behind IBS diagnoses—and identifies the clinical warning signs that should prompt doctors to test.
Djokovic's gluten-free transformation is inspiring — but celiac families need to understand the key difference between his condition and theirs.
Research shows the 10x celiac antibody threshold catches only 1 in 6 patients with intestinal damage, despite near-perfect accuracy when it does fire.
A new Swedish study challenges the theory that early antibiotic use raises celiac disease risk—what the findings mean for celiac families who've carried that worry.
New research shows celiac antibody levels fluctuate in kids with T1D, making single screenings unreliable. What families need to know about ongoing monitoring.
A Yale study using NIH's All of Us database examines whether atopic dermatitis (eczema) and celiac disease occur together more often than chance. Here is what it means for families.
A new COVIMPACT study in Nutrients maps the social and behavioral factors that drove psychological distress in celiac patients during the COVID-19 pandemic.
A new review examines emerging celiac treatments targeting immune pathways—potential options for patients who struggle with the gluten-free diet alone.
A large Swedish study finds celiac disease patients face increased risk of death, cardiovascular disease, and certain cancers—even after diagnosis and treatment.
A Swedish study tracking 48,000 celiac patients found they face 60% higher risk of needing kidney or liver transplants compared to the general population.
New research shows ARFID, a restrictive eating disorder, is surprisingly common in both children and adults with celiac disease and gluten sensitivity.
New research shows that skipping a duodenal bulb biopsy can cause doctors to miss celiac disease in children with low antibody levels—a diagnostic blind spot.
New ultrasound imaging reveals increased blood flow in parotid glands of children with celiac disease, suggesting subclinical inflammation beyond the gut.
New data analysis reveals distinct celiac subtypes in children based on antibodies, intestinal damage, and other conditions—opening doors to personalized care.
Research finds gluten exposure through kissing is extremely low risk for celiac patients—even immediately after a partner eats gluten.
New Norwegian research challenges assumptions about omega-3s and celiac disease risk, finding no protective effect in a large study of infants.
New research finds two urinary microRNAs combined with a protein test can diagnose pediatric celiac disease without blood draws or invasive procedures.
New research examines how celiac disease affects body image and emotional awareness in adults, revealing connections that matter for mental health support.
New research confirms how long couples should wait after gluten exposure before kissing safely—and the answer is simpler than many families expect.
New research reveals how flawed screening criteria in celiac drug trials may cause them to fail—not because the drugs don't work, but because they're testing the wrong patients.
A newly engineered enzyme called celiacase degrades immunogenic gluten peptides by up to 99% in lab tests, offering hope as a therapeutic adjunct to the gluten-free diet.
New research identifies molecules that could neutralize gluten before it triggers immune damage—what this means for celiac families.
A corrected Mendelian randomization study on gut microbiota and celiac disease reminds us why scientific rigor matters for the celiac community.
New research reveals 44% of patients with dermatitis herpetiformis (celiac disease of the skin) experience neurological issues, highlighting the systemic nature of celiac disease.
New research identifies perinatal and lifestyle factors that influence childhood liver enzyme levels, potentially flagging early metabolic disease risk.
New AI-driven research aims to standardize how pathologists read celiac biopsies, potentially reducing misdiagnosis and speeding up treatment.
New research finds girls with celiac disease have lower muscle mass and higher body fat than peers, even while following a gluten-free diet.
A new comprehensive review highlights why celiac disease is underdiagnosed and why the gluten-free diet remains the only treatment option.
An experimental drug shows promise for treating celiac disease beyond the gluten-free diet. What celiac families should know about this development.
New research reveals intestinal cells actively contribute to celiac disease onset, not just suffer damage. What this means for prevention and treatment.
Italian study finds denosumab effectively increases bone density in celiac patients with osteoporosis, offering hope for those at high fracture risk.
New meta-analysis reveals the gluten-free diet affects lipid profiles differently in children versus adults with celiac disease. What parents need to know.
New research explores how genetic variations in antibody genes may influence the immune response in celiac disease, offering clues for future treatments.
Columbia study finds kissing after gluten consumption poses minimal risk. Drinking water first eliminates detectable gluten transfer entirely.
Genetic analysis reveals celiac disease may increase risk of pulmonary arterial hypertension. What celiac families should know about this connection.
New research confirms what celiac families know: fatigue persists, quality of life suffers, and follow-up care is inconsistent. Here's what it means.
New research reveals what helps celiac patients stick to their gluten-free diet—and the barriers that make adherence so difficult.
New genetic research suggests celiac disease may be linked to lower Alzheimer's risk. What this means for celiac families and future research.
University of Cincinnati research reveals gut microbiome differences may influence celiac disease development, offering new clues for prevention.
A common blood pressure drug can cause intestinal damage identical to celiac disease. Here's what celiac families need to know about olmesartan.
New research quantifies the emotional and social burden on parents of celiac children. Here's what the data reveals and why it matters.
Scientists discover specialized intestinal cells that play a key role in triggering the celiac immune response, opening potential new paths for treatment.
A major review outlines promising celiac disease treatments in development, from gluten-digesting enzymes to immune tolerance therapies.
The Medical University of South Carolina breaks down celiac disease diagnosis and long-term health effects. Here's what it means for our community.
The DAISY Study is recruiting adults with celiac disease who have symptoms despite a gluten-free diet. Travel compensation included.
UC Davis researchers used gene editing to remove gluten proteins harmful to people with celiac disease. Here's what this breakthrough could mean for families.
What gluten is, how it damages the celiac intestine, hidden sources, and why FDA standards may not protect everyone.
Celiac disease explained: autoimmune condition, symptoms, diagnosis, and why 'gluten-free' isn't always safe enough.